Empros Pharma AB is a biopharmaceutical company headquartered in Stockholm, Sweden. It is developing EMP16, an investigational oral fixed-dose combination of orlistat and…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Empros Pharma AB →Already a subscriber? Sign in
Xcout Intel tracks Empros Pharma AB continuously — this profile deepens as new filings, funding, people and hiring data arrive.